This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Pulnovo Medical has closed a Series C financing round, securing around $100m for...
UCSD has initiated a clinical trial to assess Nexalin Technology's Halo Clarity ...
Adagio Medical has decided to reduce its workforce and pause an early rollout of...
Demetra Holding has acquired a 51% stake in Swiss company GetSet Surgical to exp...
Speaking at the Health Care Excellence Through Technology show, Richard Leese, d...
BillionToOne has reported outcomes from a US clinical study of its non-invasive ...
GE HealthCare has announced a leadership transition for its China operations, wi...
Teleflex is splitting its business into two independently traded entities, with ...
Identiv and Novanta have collaborated to enhance the adoption of RFID-enabled so...
Following a hefty raise by Beta Bionics last month, Kestra’s IPO means medtech h...
Results from the Phase II pivotal incontinence trial saw 42% of patients being d...
Medtronic and UK software company Brainomix are collaborating to advance stroke ...
The FDA has granted 510(k) clearance for Visby Medical’s polymerase chain reacti...
Biomerica has received CE-marking for its food intolerance tests tailored for ul...
Celebrity partnerships with medtech companies are becoming a more familiar trend...
Philips has received the EU MDR certificate for its vendor-agnostic Radiology Op...
Studies using whole genome sequencing (WGS) in newborns aim to drive earlier dia...
Olympus APAC is launching its iTind device for treating benign prostatic hyperpl...
Thermo Fisher Scientific is buying Solventum’s purification and filtration busin...
The US FDA has cleared Tandem Diabetes Care’s Control-IQ+ technology for use in ...
Fresenius Medical Care’s transformation plan has become evident in a 2024 earnin...
GE HealthCare has delivered the initial subject doses of Flyrcado (flurpiridaz F...
Danish perfusion imaging specialist Cercare Medical has completed a €7.4m ($7.7m...
Fresenius Medical Care’s transformation plan has become evident in a 2024 earnin...